About Careers MedBlog Contact us

Antibody Therapy To Detect Disease Progression of Alzheimer’s, Nervous Disorders

by Julia Samuel on April 21, 2017 at 12:54 PM
Font : A-A+

Antibody Therapy To Detect Disease Progression of Alzheimer’s, Nervous Disorders

Tauopathies, an antibody therapy may be used as a marker to screen patients for chronic traumatic encephalopathy, frontotemporal dementia, and Alzheimer's disease.

Currently, no approved treatments exist for such diseases, where neurological damage and cognitive decline occur as toxic "clumps" of a misfolded protein called tau accumulate in the brain.


One barrier to clinical trials is screening patients that have the aggregated form of the protein in their central nervous systems, and also determining if a therapy is reaching its intended target.

Based on promising results in rodents, an antibody called HJ8.5 that recognizes the pathological form of tau is now under investigation. Here, Kiran Yanamandra and colleagues showed that administering HJ8.5 increased the detectable levels of tau in the serum of four human patients with tauopathies as well as in mouse models.

Tau is typically found inside neurons, but researchers believe that accumulations in the spaces outside of brain cells are responsible for driving the diseases' pathologies.

The scientists correlated the amount of tau in the brain with serum protein levels in mice, demonstrating that the higher levels of tau observed after treatment reflected increased serum-stability of the protein (which typically has a short half-life in the blood and is as such often undetectable).

The authors say it will be important to assess plasma tau across different patient populations as anti-tau antibodies move forward into clinical trials.

Source: Eurekalert


Latest Research News

 Blind People Feel Their Heartbeat Better Than Those With Sight
Brain plasticity following blindness leads to superior ability in sensing signals from the heart, which has implications for bodily awareness and emotional processing.
New Biomarkers Help Detect Alzheimer's Disease Early
A group of scientists were awarded Ł1.3 million to create a new “point of care testing” kit that detects Alzheimer's disease biomarkers.
Bone Health and Dementia: Establishing a Link
Is there a connection between Osteoporosis and dementia? Yes, loss in bone density may be linked to an increased risk of dementia in older age.
Is Telomere Shortening a Sign of Cellular Aging?
Link between chromosome length and biological aging marker discovered. The finding helps explain why people with longer telomeres have a lower dementia risk.
Why Is Integrated Structural Biology Important for Cystic Fibrosis?
Integrated structural biology helps discover how the cystic fibrosis transmembrane conductance regulator (CFTR) works.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Antibody Therapy To Detect Disease Progression of Alzheimer’s, Nervous Disorders Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests